Water-dispersable nanoparticles

ABSTRACT

Provided herein are methods for making water-soluble nanoparticles comprising a core/shell nanocrystal that is coated with a surface layer comprising enough hydrophilic ligands to render the nanoparticle water soluble or water dispersable. Methods for crosslinking molecules on the surface of a nanoparticle, which methods can be used on the above water-soluble nanoparticles also are provided. Nanoparticle compositions resulting from these methods are also provided.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a Division of U.S. application Ser. No. 13/057,504,filed Aug. 29, 2011, which is a 371 national stage application fromPCT/US2009/053018, filed Aug. 6, 2009, and claims benefit of 61/086,750,filed Aug. 6, 2008, which disclosures are herein incorporated byreference in their entirety.

TECHNICAL FIELD

This disclosure relates to nanoparticles and methods of synthesizingnanoparticles. More particularly, this disclosure describesnanoparticles containing a fluorescent core/shell nanocrystal plus acoating layer that provides a surface such that the nanoparticle isreadily dispersable in water as well as methods for making suchnanoparticles.

BACKGROUND

Nanocrystals are fluorescent particles that are widely used to studybiochemical and even biological systems, because they are easilyvisualized and tracked. They serve as labels that are easily observed bytheir fluorescence emissions, and permit a user to track them to studythe location, transport, or environment of biochemicals or cells thatare attached to a nanocrystal. Or a nanocrystal can be linked to aspecific affinity agent like an antibody, and can then be used tovisualize the corresponding antigen, to learn about its location,transport or environment. Because of their widespread use in biochemicaland biological systems, it is important to make nanocrystals compatiblewith those systems. One aspect of compatibility is water solubility:while a nanocrystal is a particle that does not truly dissolve, itbehaves in many ways like a soluble molecule because of its small size.Thus a nanoparticle that has a surface adapted to be compatible withwater often behaves as though it were soluble in water, and will attimes be referred to herein as water-soluble even though it may moreproperly be viewed as water-dispersable.

Methods for making core/shell nanocrystals that are fluorescent and havehydrophobic surfaces are well known. The hydrophobic surfaces of thesenanocrystals typically result from a coating of hydrophobic passivatingligands such as trioctylphosphine (TOP), trioctylphosphine oxide (TOPO),oleic acid, octylphosphonic acid (OPA) or tetradecylphosphonic acid(TDPA) on the surface of the particle. These hydrophobic passivatingligands serve many roles, including, but not limited to: protecting thesurface of the nanocrystal by keeping reactive molecules (and even thesolvent) away from the nanocrystal surface, prevent the coalescence ofmultiple nanoparticles, prevent “dangling bonds and other similarsurface defects that could serve as trap sites for an excited electronor hole and thereby promote non-radiative recombination (i.e., reducethe quantum yield), or protect the nanocrystal from reactions that couldoccur when it is in a photoactivated state. These ligands provide alayer of alkyl groups that form the solvent-exposed surface surroundingthe nanocrystal, and thus they render the nanocrystal effectivelyhydrophobic, regardless of the properties of the nanocrystal surfaceitself. These intimately associated ligands and the nanocrystal they areassociated with form a nanoparticle. Because the surface of thenanocrystal has many binding sites for such ligands, these ligands arepacked onto the surface of the nanocrystal to form a surface layer ofligand molecules. This typically results in coating most or all of theexposed surface of the nanocrystal with a layer of alkyl groups hangingoff of the ligands, and produces a nanocrystal with a surface that isvery hydrophobic, i.e., incompatible with water.

Several ways of modifying nanocrystals to make them more water-solublehave been reported. One successful approach involves using thehydrophobic nature of the exposed surface to adhere a hydrophilicmoiety. Adams, et al. (U.S. Pat. No. 6,649,138) used this approach: theyconstructed amphiphilic polymers having polar groups (carboxylates) andlong-chain alkyl groups (hydrophobic domains), and introduced theseamphiphilic polymers onto the hydrophobic surface of conventionalnanocrystals. The hydrophobic domains of the AMPs ‘stick’ to thehydrophobic surface layer of the nanoparticles, exposing the polarcarboxylates of the AMP to the exterior environment. This makesnanoparticles that have an outermost surface that is sufficiently polarto make the nanoparticle water soluble. This approach works well forcertain applications, but it results in adding an additional layer onthe outside of a nanocrystal, so it actually makes the nanoparticlelarger.

Others have approached this problem by replacing the typicalphosphine/phosphine oxide or other hydrophobic ligands with smallermoieties that do not have the long, hydrophobic alkyl groups thatproduce a hydrophobic surface on a conventional nanocrystal. Naasani, etal., for example, produced nanocrystals having relatively polardipeptides on their surfaces. U.S. Pat. No. 6,955,855. These dipeptidesuse a binding group, e.g., imidazole ring, to coordinate to thenanocrystal surface, and they have a carboxylate and an amine inaddition to the binding group that can be free to promote watersolubility and/or to participate in crosslinking. This provided a muchsmaller nanoparticle than those of Adams, et al., and also provided asurface that was sufficiently polar to make the nanoparticlewater-dispersable.

For some applications, there are certain advantages to making ananoparticle as small as possible, especially for certain biologicalapplications. For example, smaller particles diffuse more rapidly, haveless effect on a molecule they are attached to, and may have lesstendency to accumulate in specific tissues in vivo, where largerparticles seem to get trapped by ‘filtration’ effects. See, e.g.,Ballou, et al., Bioconjugate Chem., vol. 15, 79-86 (2004). Thus bettermethods for making nanocrystals into water-soluble nanoparticles areneeded, preferably methods that keep these nanoparticles as small aspossible while making them highly stable and maintaining their essentialfluorescence characteristics. This disclosure provides methods forachieving such objectives, and thus provides compositions and methodsthat produce improved nanoparticles, especially small, stable,water-soluble ones.

SUMMARY

Provided herein are nanocrystals that are water-soluble or dispersable,and are also bright and chemically and photochemically stable. Furtherprovided are robust cross-linking methods applicable to crosslinking alayer of ligands on a nanoparticle surface that promote chemicalstability and reduce ‘dilution dimming’ In addition, disclosed herewithare novel processes for modifying the surface of a nanoparticle that aremore efficient and provide more consistent products. The nanoparticlesprovided herein can readily be linked to a target molecule or cell, etc.of interest. The methods result in small, bright nanoparticles withimproved chemical stability and photostability, which can be used inespecially demanding applications. Furthermore, disclosed herewith arenovel compositions of water soluble nanoparticles. The compositions andmethods disclosed herein may be useful for various biologicalapplications, including, but not limited to: cell staining, celltracking, in vivo imaging, in vitro imaging, blots, flow cytometry,FISH, and other biological applications.

In one aspect, a method for making a water-dispersable nanoparticle, isprovided, comprising:

-   -   a) providing a nanocrystal coated with a surface layer        comprising a hydrophobic ligand, and dissolved or dispersed in a        non-aqueous solvent;    -   b) contacting the nanocrystal dispersion with a phase transfer        agent and an aqueous solution comprising a hydrophilic ligand,        to form a biphasic mixture having an aqueous phase and a        non-aqueous phase; and    -   c) maintaining the mixture under conditions that cause the        nanocrystal to migrate from the non-aqueous solvent into the        aqueous phase.

In another aspect, a method for making a water-dispersable nanoparticle,is provided, comprising:

-   -   a) providing a nanocrystal coated with a surface layer        comprising a hydrophobic ligand, and dissolved or dispersed in a        non-aqueous solvent;    -   b) contacting the nanocrystal dispersion with at least one        cosolvent and an aqueous solution comprising a hydrophilic        ligand, to form a biphasic mixture having an aqueous phase and a        non-aqueous phase; and    -   c) maintaining the mixture under conditions that cause the        nanocrystal to migrate from the non-aqueous solvent into the        aqueous phase;        -   wherein the at least one cosolvent has some miscibility in            both the aqueous phase and the non-aqueous phase.

In another aspect, a method for making a crosslinked surface on ananoparticle, is provided. This method of cross-linking the surfacelayer on a nanoparticle comprises:

-   -   a. providing a nanocrystal that is dispersed in a suitable        solvent;    -   b. adding a crosslinking agent and/or at least one peptide        bond-forming reagent; and    -   c. incubating the dispersion under suitable conditions to        promote crosslinking of the surface layer.

In another aspect, a population of nanoparticles, is provided. Thepopulation including a plurality of nanoparticles; wherein eachnanoparticle includes a nanocrystal core including a first semiconductormaterial, a shell including a second semiconductor material, and anouter layer that imparts hydrophilic properties to the nanoparticle;wherein the outer layer is comprised of a plurality of hydrophilicligands and a plurality of phosphonic acid ligands each with at leastone linking group for attachment to a surface of the shell; and whereinthe ratio of the plurality of hydrophilic ligands to the plurality ofphosphonic acid ligands is at least about 0.1:1.

In another aspect, a population of nanoparticles, is provided. Thepopulation including a plurality of nanoparticles; wherein eachnanoparticle includes a nanocrystal core including a first semiconductormaterial, a shell including a second semiconductor material, and anouter layer that imparts hydrophilic properties to the nanoparticle;wherein the outer layer is comprised of a plurality of dihydrolipoicacid (DHLA) ligands and a plurality of phosphonic acid ligands each withat least one linking group for attachment to a surface of the shell; andwherein the ratio of the plurality of DHLA ligands to the plurality ofphosphonic acid ligands is at least about 0.25:1.

In another aspect, a population of nanoparticles, is provided. Thepopulation including a plurality of nanoparticles; wherein eachnanoparticle includes a nanocrystal core including a first semiconductormaterial, a shell including a second semiconductor material, and anouter layer that imparts hydrophilic properties to the nanoparticle;wherein the outer layer is comprised of a plurality of tridentate thiolligands and a plurality of phosphonic acid ligands each with at leastone linking group for attachment to a surface of the shell; and whereinthe ratio of the plurality of tridentate thiol ligands to the pluralityof phosphonic acid ligands is at least about 0.5:1.

These nanoparticles can be attached to various biomolecules and bindingmoieties and used to track them or to monitor their movements andinteractions with other moieties, both in vitro and in vivo.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows a TOPO coated core/shell nanocrystal combining with anamphiphilic octylamine-modified polyacrylic acid to form a complexhaving carboxylic acid groups on its outer surface to provide watersolubility.

FIG. 2 illustrates the observation that nanoparticles typically arestable in solution as a colloid over a certain concentration range, butthat they begin to aggregate or precipitate at higher concentrations,and tend to lose fluorescence intensity (“dilution dimming”) andeventually precipitate at very low concentrations.

FIG. 3 shows how fluorescence emissions of a cross-linkeddipeptide-coated nanocrystal fares over time at a low concentration (70nM) in 50 mM borate buffer at pH 8.3. Fluorescence intensity ismaintained much longer by the nanoparticle with a cross-linked coatingthan by a nanoparticle having AMP ligands to provide water solubility,as disclosed by Adams, et al.

FIG. 4A shows how butanol additive causes nanoparticles to migrate froma non-aqueous (upper) phase into the aqueous (lower) phase in a biphasicmixture, as hydrophilic ligands from the aqueous phase displacedhydrophobic ligands to make the nanoparticle water soluble.

FIG. 4B shows how 18-crown-6 additive causes nanoparticles to migratefrom a non-aqueous (upper) phase into the aqueous (lower) phase in abiphasic mixture, as hydrophilic ligands from the aqueous phasedisplaced hydrophobic ligands to make the nanoparticle water soluble.

FIG. 4C shows how tetraoctylammonium bromide additive causesnanoparticles to migrate from a non-aqueous (upper) phase into theaqueous (lower) phase in a biphasic mixture, as hydrophilic ligands fromthe aqueous phase displaced hydrophobic ligands to make the nanoparticlewater soluble.

FIG. 4D shows how tetrabutylammonium chloride additive causenanoparticles to migrate from a non-aqueous (upper) phase into theaqueous (lower) phase in a biphasic mixture, as hydrophilic ligands fromthe aqueous phase displaced hydrophobic ligands to make the nanoparticlewater soluble.

FIG. 5 shows a plot of XPS data for a hydrophobic coating on anas-prepared core/shell nanoparticle.

FIG. 6 shows a plot of XPS data for relative surface content for a TDPAcoating on a DHLA coated core/shell nanoparticle.

FIG. 7 shows a plot of XPS data for relative surface content for a DHLAcoating on a DHLA coated core/shell nanoparticle.

FIG. 8A is a compound of Formula I.

FIG. 8B is a compound of Formula II.

FIG. 8C is a compound of Formula III.

FIG. 8D is a compound of Formula IV.

FIG. 8E is a compound of Formula V.

FIG. 8F is a compound of Formula VI.

FIG. 8G is a compound of Formula VII.

FIG. 8H is a compound of Formula VIII.

FIG. 8I is a compound of Formula IX.

FIG. 8J is a compound of Formula X.

FIG. 8K is a compound of Formula XI.

FIG. 8L is a compound of Formula XII.

FIG. 8M is a compound of Formula XIII.

FIG. 8N is a compound of Formula XIV.

FIG. 8O is a compound of Formula XV.

FIG. 8P is a compound of Formula XVI.

FIG. 8Q is a compound of Formula XVII.

FIG. 8R is a compound of Formula XVIII.

FIG. 8S is a compound of Formula XIX.

FIG. 8T is a compound of Formula XX.

FIG. 8U is a compound of Formula XXI.

FIG. 8V is a compound of Formula XXII.

FIG. 8W is a compound of Formula XXIII

FIG. 9 is a table showing relative surface content of select exchangedhydrophilic ligands to TDPA ligand.

DETAILED DESCRIPTION

The embodiments disclosed herein may be understood more readily byreference to the following detailed description of the embodimentsdisclosed herein and the Examples included herein. It is to beunderstood that the terminology used herein is for the purpose ofdescribing specific embodiments only and is not intended to be limiting.

Unless defined otherwise, all technical and scientific terms used hereinhave the same meaning as is commonly understood by one of ordinary skillin the art to which embodiments disclosed herein belongs.

As used herein, “a” or “an” means “at least one” or “one or more.”

As used herein, “about” means that the numerical value is approximateand small variations would not significantly affect the practice of theembodiments disclosed herein. Where a numerical limitation is used,unless indicated otherwise by the context, “about” means the numericalvalue can vary by ±10% and remain within the scope of the embodimentsdisclosed herein.

As used herein, the terms “alkyl,” “alkenyl” and “alkynyl” includestraight-chain, branched-chain and cyclic monovalent hydrocarbylradicals, and combinations thereof, which contain only C and H when theyare unsubstituted. Examples include, but are not limited to, methyl,ethyl, isobutyl, cyclohexyl, cyclopentylethyl, 2-propenyl, 3-butynyl,and the like. The total number of carbon atoms in each such group issometimes described herein, e.g., when the group can contain up to tencarbon atoms it may be described as 1-10C or as C₁-C₁₀ or as C₁₋₁₀. Whenheteroatoms (such as N, O and S) are allowed to replace carbon atoms ofan alkyl, alkenyl or alkynyl group, as in heteroalkyl groups, forexample, the numbers describing the group, though still written as e.g.C₁-C₆, represent the sum of the number of carbon atoms in the group plusthe number of such heteroatoms that are included as replacements forcarbon atoms in the ring or chain being described.

Typically, the alkyl, alkenyl and alkynyl substituents of theembodiments described herein contain, but are not limited to, 1-10C(alkyl) or 2-10C (alkenyl or alkynyl). Sometimes they contain 1-8C(alkyl) or 2-8C (alkenyl or alkynyl). Preferably, they contain 1-6C(alkyl) or 2-6C (alkenyl or alkynyl). Sometimes they contain 1-4C(alkyl) or 2-4C (alkenyl or alkynyl). A single group can include morethan one type of multiple bond, or more than one multiple bond; suchgroups are included within the definition of the term “alkenyl” whenthey contain at least one carbon-carbon double bond, and they areincluded within the term “alkynyl” when they contain at least onecarbon-carbon triple bond.

Alkyl, alkenyl and alkynyl groups are often substituted to the extentthat such substitution can chemically occur. Typical examples ofsubstituents can include, but are not limited to, halo, acyl,heteroacyl, carboxylic acid, sulfonic acid, primary or secondary amine,thiol, hydroxyl, or an activated derivative thereof, or a protected formof one of these. Alkyl, alkenyl and alkynyl groups can also besubstituted by C1-C8 acyl, C2-C8 heteroacyl, C6-C10 aryl or C5-C10heteroaryl, each of which can be substituted by the substituents thatare appropriate for the particular group.

As used herein, “acyl” encompasses groups comprising an alkyl, alkenyl,alkynyl, aryl or arylalkyl radical attached at one of the two availablevalence positions of a carbonyl carbon atom, e.g., —C(═O)R where R canbe an alkyl, alkenyl, alkynyl, aryl, or arylalkyl group, and heteroacylrefers to the corresponding groups wherein at least one carbon otherthan the carbonyl carbon has been replaced by a heteroatom chosen fromN, O and S. Thus heteroacyl includes, for example, —C(═O)OR and—C(═O)NR₂ as well as —C(═O)-heteroaryl, where each R is independently H,or C1-C8 alkyl.

“Aromatic” moiety or “aryl” moiety refers to a monocyclic or fusedbicyclic moiety having the well-known characteristics of aromaticity;examples include, but are not limited to, phenyl and naphthyl.Similarly, “heteroaromatic” and “heteroaryl” refer to such monocyclic orfused bicyclic ring systems which contain as ring members one or moreheteroatoms (such as O, S and N). The inclusion of a heteroatom permitsaromaticity in 5-membered rings as well as 6-membered rings. Typicalheteroaromatic systems include, but are not limited to, monocyclic C5-C6aromatic groups such as pyridyl, pyrimidyl, pyrazinyl, thienyl, furanyl,pyrrolyl, pyrazolyl, thiazolyl, oxazolyl, and imidazolyl, and the fusedbicyclic moieties formed by fusing one of these monocyclic groups with aphenyl ring or with any of the heteroaromatic monocyclic groups to forma C8-C10 bicyclic group such as indolyl, benzimidazolyl, indazolyl,benzotriazolyl, isoquinolyl, quinolyl, benzothiazolyl, benzofuranyl,pyrazolopyridyl, quinazolinyl, quinoxalinyl, cinnolinyl, and the like.Preferably aryl groups contain 6-10 ring members, and heteroaryl groupscontain 5-10 ring members.

Aryl and heteroaryl moieties may be substituted with a variety ofsubstituents including C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C5-C12aryl, C1-C8 acyl, and heteroforms of these, each of which can itself befurther substituted; other substituents for aryl and heteroaryl moietiescan include halo, OR, NR₂, SR, SO₂R, SO₂NR₂, NRSO₂R, NRCONR₂, NRCOOR,NRCOR, CN, COOR, CONR₂, OOCR, —C(O)R, and NO₂, wherein each R isindependently H, or C1-C8 alkyl.

“Nanoparticle” as used herein refers to any particle with at least onemajor dimension in the nanosize range. Typically, a nanoparticle has atleast one major dimension ranging from about 1 to 1000 nm.

Examples of nanoparticles include a nanocrystal, such as a core/shellnanocrystal, plus any tightly-associated organic coating or othermaterial that may be on the surface of the nanocrystal. A nanoparticlemay also include a bare core nanocrystal, as well as a core nanocrystalor a core/shell nanocrystal having a layer of, e.g., TOPO or othermaterial that is not removed from the surface by ordinary solvation. Ananoparticle may have a layer of ligands on its surface which mayfurther be cross-linked; and a nanoparticle may have other or additionalsurface coatings that modify the properties of the particle, forexample, solubility in water or other solvents. Such layers on thesurface are included in the term ‘nanoparticle’;

“Nanocrystal” as used herein refers to a nanoparticle made out of aninorganic substance that typically has an ordered crystalline structure.It can refer to a nanocrystal having a crystalline core, or to acore/shell nanocrystal, and may be 1-100 nm in its largest dimension,preferably about 1 to 50 nm in its largest dimension.

A core nanocrystal is a nanocrystal to which no shell has been applied;typically it is a nanocrystal, and typically it can be made of a singleor a multitude of semiconductor materials. It may be homogeneous, or itscomposition may vary with depth inside the nanocrystal. Many types ofnanocrystals are known, and methods for making a nanocrystal core andapplying a shell to it are known in the art. The nanocrystalsembodiments disclosed herein are frequently bright fluorescentnanocrystals, and the nanoparticles prepared from them are generallybright and stable, providing a quantum yield of greater than about 20%,or greater than about 30%, or greater than about 50%, or greater thanabout 70%.

As used herein, the term “population” refers to a solution or structurewith more than one nanocrystal.

Nanocrystals generally have a surface layer of ligands to protect thenanocrystal from degradation in use or during storage.

The nanocrystal core and shell can be made of any suitable metal (e.g.,Au, Co) and/or non-metal atoms that are known to form nanocrystals.Suitable materials for the core and/or shell include, but are notlimited to, ones including Group 2-16, 12-16, 13-15 and 14 element-basedsemiconductors such as ZnS, ZnSe, ZnTe, CdS, CdSe, CdTe, HgS, HgSe,HgTe, MgS, MgSe, MgTe, CaS, CaSe, CaTe, SrS, SrSe, SrTe, BaS, BaSe,BaTe, GaN, GaP, GaAs, GaSb, InP, InAs, InSb, AlAs, AlP, AlSb, PbS, PbSe,Ge and Si and ternary and quaternary mixtures thereof. Typically, thecore and the shell of a core/shell nanocrystal are composed of differentsemiconductor materials, meaning that at least one atom type of a binarysemiconductor material of the core of a core/shell is different from theatom types in the shell of the core/shell nanocrystal.

“Quantum dot” as used herein refers to a nanocrystalline particle madefrom a material that in the bulk is a semiconductor or insulatingmaterial, which has a tunable photophysical property in the nearultraviolet (UV) to far infrared (IR) range.

“Water-soluble” or “water-dispersable” is used herein to mean the itemis soluble or suspendable in an aqueous-based solution, such as in wateror water-based solutions or buffer solutions, including those used inbiological or molecular detection systems as known by those skilled inthe art. While water-soluble nanoparticles are not truly ‘dissolved’ inthe sense that term is used to describe individually solvated smallmolecules, they are solvated and suspended in solvents that arecompatible with their outer surface layer, thus a nanoparticle that isreadily dispersed in water is considered water-soluble orwater-dispersible. A water-soluble nanoparticle is also consideredhydrophilic, since its surface is compatible with water and with watersolubility.

“Hydrophobic nanoparticle” as used herein refers to a nanoparticle thatis readily dispersed in or dissolved in a water-immiscible solvent likehexanes, toluene, and the like. Such nanoparticles are generally notreadily dispersed in water.

“Hydrophilic” as used herein refers to a surface property of a solid, ora bulk property of a liquid, where the solid or liquid exhibits greatermiscibility or solubility in a high-dielectric medium than it does in alower dielectric medium. By way of example, a material that is moresoluble in methanol than in a hydrocarbon solvent such as decane wouldbe considered hydrophilic.

“Coordinating solvents” as used herein refers to a solvent such as TDPA,OPA, TOP, TOPO, carboxylic acids, and amines, which are effective tocoordinate to the surface of a nanocrystal. ‘Coordinating solvents’ alsoinclude phosphines, phosphine oxides, phosphonic acids, phosphinicacids, amines, and carboxylic acids, which are often used in growthmedia for nanocrystals, and which form a coating or layer on thenanocrystal surface. They exclude hydrocarbon solvents such as hexanes,toluene, hexadecane, octadecene, and the like, which do not haveheteroatoms that provide bonding pairs of electrons to coordinate withthe nanocrystal surface. Hydrocarbon solvents that do not containheteroatoms such as O, S, N or P to coordinate to a nanocrystal surfaceare referred to herein as non-coordinating solvents. Note that the term‘solvent’ is used in its ordinary way in these terms: it refers to amedium that supports, dissolves, or disperses materials and reactionsbetween them, but which does not ordinarily participate in or becomemodified by the reactions of the reactant materials. However, in certaininstances, the solvent is modified by the reaction conditions. Forexample, TOP may be oxidized to TOPO, or a carboxylic acid may bereduced to an alcohol.

Nanoparticles can be synthesized in shapes of different complexity suchas spheres, rods, discs, triangles, nanorings, nanoshells, tetrapods,nanowires and so on. Each of these geometries has distinctiveproperties: spatial distribution of the surface charge, orientationdependence of polarization of the incident light wave, and spatialextent of the electric field. In some embodiments, the nanocrystals areroughly spherical.

In some embodiments, the nanoparticle may be a core/shell nanocrystalhaving a nanocrystal core covered by a semiconductor shell. Thethickness of the shell can be adapted to provide desired particleproperties. The thickness of the shell can also affect fluorescencewavelength, quantum yield, fluorescence stability, and otherphotostability characteristics.

In one aspect, a method to make a water-soluble nanoparticle startingwith a hydrophobic nanoparticle comprising a nanocrystal coated with asurface of hydrophobic ligands, by replacing the hydrophobic ligands onthe nanocrystal with hydrophilic ones, is disclosed.

Typically, the nanocrystal used for this process is a core/shellnanocrystal that is coated with a hydrophobic ligand such astetradecylphosphonic acid (TDPA), trioctylphosphine oxide (TOPO),trioctyl phosphine (TOP), octylphosphonic acid (OPA), and the like, or amixture of such ligands; these hydrophobic ligands typically have atleast one long-chain alkyl group, i.e. an alkyl group having at least 8carbons, or for the phosphine/phosphine oxide ligands, this hydrophobiccharacter may be provided by two or three alkyl chains on a singleligand molecule having a total of at least 10 carbon atoms. Therefore,in some embodiments, the surface of the core/shell nanoparticle orpopulations thereof can be coated with varying quantities of TDPAhydrophobic ligands prior to replacement with hydrophilic ligand(s). Forexample, TDPA can represent at least about 10%, at least about 20%, atleast about 30%, at least about 40%, at least about 50%, at least about80%, at least about 95%, at least about 98%, at least about 99%, or moreof the total surface ligands coating the core/shell nanoparticles.Moreover, certain hydrophobic ligands show an unexpected and apparentease of replacement with the hydrophilic ligand. For example,nanoparticles with OPA on the surface have been observed to transferinto aqueous buffer more readily and more completely than the same typeof core-shell with TDPA on the surface. Therefore, in some embodiments,the surface of the core/shell nanoparticle or populations thereof can becoated with varying quantities of OPA hydrophobic ligands prior toreplacement with hydrophilic ligand(s). For example, OPA can representat least about 10%, at least about 20%, at least about 30%, at leastabout 40%, at least about 50%, at least about 80%, at least about 95%,at least about 98%, at least about 99%, or more of the total surfaceligands coating the core/shell nanoparticles.

In some embodiments, the nanocrystal coated with hydrophobic ligands isdissolved in a non-aqueous solvent, preferably one that is not misciblewith water under the conditions used. The dispersion of the nanocrystalcan optionally be contacted with a phase transfer agent or at least onecosolvent, and an aqueous mixture comprising a hydrophilic ligand. Insome embodiments the resultant mixture can be monophasic. In otherembodiments, the resultant mixture can be biphasic, especially where theaqueous and non-aqueous phases are immiscible under the conditions used.In some embodiments, the phase transfer agent or the cosolvent can becombined with either the aqueous or non-aqueous solutions prior toformation of the biphasic mixture. In other embodiments, the phasetransfer agent or the cosolvent can be added after formation of thebiphasic mixture. The nanocrystal will ordinarily remain in thenon-aqueous phase unless at least some hydrophobic ligands on thenanocrystal surface desorb from the nanocrystal and are replaced byhydrophilic ligands, because the hydrophobic ligands initially on thenanocrystal surface are incompatible with dispersal in the aqueousphase.

In some embodiments, a phase transfer catalyst can be used to facilitatethe ligand exchange process, as further described herein. In otherembodiments, at least one cosolvent having some miscibility in both theaqueous and non-aqueous phases can be used to facilitate the ligandexchange reaction. In some such embodiments, one cosolvent can be usedin the contacting step; in other embodiments, two or more cosolvents areused in the contacting step.

In general, the hydrophilic ligand has limited solubility in thenon-aqueous phase, and the hydrophobic nanoparticle does not typicallygo into the aqueous phase; and the nanoparticle's surface layer istypically stable at room temperature. Thus heating may be desired toinduce and/or accelerate ligand exchange. The mixture can be heated to atemperature up to the boiling point of the lower-boiling of the twophases. In some embodiments, the mixture is heated to a temperaturebetween about 40° C. and 100° C. In some embodiments, the mixture isheated to a temperature between about 50° C. and 80° C. In someembodiment, the mixture is heated to a temperature between about 50° C.and 70° C.

However, it should be appreciated that in some embodiments, heating maynot be necessary to induce the ligand exchange process. That is, it hasbeen observed that nanocrystal shape and emission characteristics (e.g.,size) may impact whether heating is required to induce ligand exchangeto occur.

The mixture can be maintained at any suitable pressure during thisprocess; elevated pressure can be used if it is desired to operate at atemperature above the boiling point of the organic solvent. Suitably,however, the monophasic or biphasic mixture can be heated at ambientpressure. In some embodiments, this process can be conducted underconditions that are free of oxygen, or at least substantially free ofoxygen; nitrogen or argon can be used to provide an oxygen-freeatmosphere for the reaction.

In some cases, it may be desirable to use alternative approaches insteadof or in addition to heating. For example, the use of sonication,agitation or stirring can facilitate the ligand transfer process, withor without heating.

Ligand exchange of hydrophobic ligands for hydrophilic ones on thenanoparticle surface occurs in this process and is believed to precedeand induce migration of the nanoparticle from non-aqueous to aqueousphase. The ligand exchange process can be accelerated by a cosolvent ora phase transfer catalyst. For example, a number of different substanceshave been found to be useful for this accelerant; butanol has been usedto promote the exchange reaction, but even with relatively large amountsof n-butanol, the exchange process may require prolonged heating toeffect complete migration of the nanocrystal from the non-aqueous phaseinto the aqueous phase. In some embodiments, other accelerants can bemore effective than butanol, including phase transfer agents such asPEG, crown ethers, alkyl ammonium salts (e.g., mono-, di-, tri- andtetraalkyl ammonium salts), tetralkylphosphonium salts, and trialkylsulfonium salts.

Suitable temperature, time and concentration parameters for this processare readily determined by routine experimentation, because the progressof the reaction can be easily monitored by observing the migration ofthe nanoparticles from the non-aqueous phase into the aqueous phase.Migration occurs as ligand exchange reaches an extent that is sufficientfor the hydrophilic ligand on the nanoparticle to overcome thehydrophobic effect of the hydrophobic ligand. Migration may occur beforeligand exchange is complete; thus the nanoparticles in the aqueous phasemay contain a mixture of hydrophobic and hydrophilic ligands on theirsurface. Continued heating then can promote further ligand exchange, soexchange can be driven to completion by continued heating in thepresence of excess hydrophilic ligand.

The hydrophilic ligand can be any compound that provides at least onebinding (linking) group having strong affinity for the nanocrystalsurface along with additional polar functionality to promote watersolubility when the binding group is held at the surface of thenanocrystal. In some embodiments, it may be desirable for the compoundto include a plurality of binding groups that have affinity for thenanocrystal surface. For example, the compound may be a polydentate(e.g., bidentate, tridentate, etc.) ligand having two or more linkinggroups that attach to the nanocrystal surface. Suitable binding groupscan include any compound having electron pairs available for interactionwith the core/shell nanocrystal surface, such as oxygen (O), sulfur (S),nitrogen (N) and phosphorous (P). Suitable polar functional groupsinclude, by way of example and not limitation, amines (e.g., primary,secondary and tertiary amines), carboxylates, phosphonates,phosphinates, amides, hydroxyls, thiols, polar heterocycles, such asimidazoles and pyridones, and the like.

Some suitable examples of the hydrophilic ligand are disclosed, forexample, in Naasani, U.S. Pat. Nos. 6,955,855; 7,198,847; 7,205,048;7,214,428; and 7,368,086. Suitable hydrophilic ligands also includeimidazole containing compounds such as peptides, particularlydipeptides, having at least one histidine residue, and peptides,particularly dipeptides, having at least one cysteine residue. Specificligands of interest for this purpose can include carnosine (whichcontains beta-alanine and histidine); His-Leu; Gly-His; His-Lys;His-Glu; His-Ala; His-His; His-Cys; Cys-His; His-Ile; His-Val; and otherdipeptides where His or Cys is paired with any of the common alpha-aminoacids; and tripeptides, such as Gly-His-Gly, His-Gly-His, and the like.The chiral centers in these amino acids can be the naturalL-configuration, or they can be of the D-configuration or a mixture of Land D. Thus a dipeptide having two chiral centers such as His-Leu can beof the L,L-configuration, or it can be L,D- or D,L; or it can be amixture of diastereomers.

Furthermore, suitable hydrophilic ligands can also include mono- orpolydentate thiol containing compounds, for example: monodentate thiolssuch as mercaptoacetic acid, bidentate thiols such as dihydrolipoic acid(DHLA), tridentate thiols such as compounds of Formula I, II, III, IV,V, or VI (see, FIG. 8A, FIG. 8B, FIG. 8C, FIG. 8D, FIG. 8E and FIG. 8F),and the like.

In compounds of Formula I, II, III, IV, V, and VI, R¹, R², R³ canindependently be H, halo, hydroxyl, (—(C═O)—C₁-C₂₂, —(C═O)CF₃,)alkanoyl, C₁-C₂₂ alkyl, C₁-C₂₂ heteroalkyl, ((CO)OC₁-C₂₂)alkylcarbonato, alkylthio (C₁-C₂₂) or (—(CO)NH(C₁-C₂₀) or—(CO)N(C₁-C₂₀)₂) alkylcarbamoyl. In some embodiments, R¹, R², and R³ aredifferent. In other embodiments, R¹, R², and R³ are the same.

In compounds of Formula I, II, III, IV, V, and VI, R⁴, and R⁵ canindependently be H, C₁-C₂₀ alkyl, C₆-C₁₈ aryl, C₁-C₂₂ heteroalkyl, orC₁-C₂₂ heteroaryl. In some embodiments, R⁴ and R⁵ are different. Inother embodiments, R⁴ and R⁵ are the same.

In compounds of Formula I, II, III, IV, V, and VI, R⁶ can be H or apolyethylene glycol based moiety of Formula VII (see FIG. 8G):

In certain embodiments of Formula VII, R⁷ can be —NH₂, —N₃, —NHBoc,—NHFmoc, —NHCbz, —COOH, —COOt-Bu, —COOMe, iodoaryl, hydroxyl, alkyne,boronic acid, allylic alcohol carbonate, —NHBiotin, —(CO)NHNHBoc,—(CO)NHNHFmoc, or —OMe. In some embodiments, n can be an integer from 1to 100.

In still further embodiments, the tridentate thiol ligands can be acompound of Formula VIII, IX, X, XI, XII, XIII, XIV, XV, XVI, XVII,XVIII, XIX, XX, XXI, XXII, or XXIII (see, FIG. 8H, FIG. 8I, FIG. 8J,FIG. 8K, FIG. 8L, FIG. 8M, FIG. 8N, FIG. 8O, FIG. 8P, FIG. 8Q, FIG. 8R,FIG. 8S, FIG. 8T, FIG. 8U, FIG. 8V and FIG. 8W):

For the exchange reaction, the hydrophilic ligand is typically dissolvedin water or a buffer such as carbonate or borate. The ligandconcentration can be in a range of about 0.1 mM to about 2 M, and isoften between about 10 mM and 1 M, and frequently between about 20 mMand about 500 mM. The ligand solution is contacted with a solution ofhydrophobic nanoparticles dissolved in a hydrocarbon or otherhydrophobic solvent that is immiscible with water; hexanes can be usedfor this solvent, or petroleum ether, heptanes, cyclohexane, octanes,toluene, and the like can be used. This produces a monophasic orbiphasic mixture that can be agitated, sonicated or stirred to promoteligand exchange. A cosolvent or phase transfer agent can be used toaccelerate this reaction. Butanol, propanol, isopropanol and ethanol areexamples of suitable cosolvents that can be used in this process. Othersuitable cosolvents include, but are not limited to, ethylene glycol,methoxyethanol, dioxane, DME, THF, acetone, acetonitrile, nitromethane,and DMSO. These cosolvents can be used in an amount that does not causethe two layers to become miscible, and in an amount that does not causethe hydrophilic ligand to precipitate from the aqueous layer.

Instead of a cosolvent, it is sometimes advantageous to use a phasetransfer agent. In addition to butanol, several different types of phasetransfer agents have also been found to effectively promote ligandexchange. Suitable phase transfer agents include, but are not limitedto, alkylammonium, trialkylsulfonium, tetraalkylphosphonium, and similarsalts having a hydrophobic cationic component, as well as PEGs and crownethers. Each alkyl portion of each alkylammonium, trialkylsulfonium, ortetraalkylphosphonium can be a saturated or unsaturated C₁-C₂₀ alkylgroup or it can contain a phenyl ring in combination with such an alkylgroup (e.g., benzyl or phenylethyl can be used). Preferably each alkylportion is selected from methyl, ethyl, propyl, isopropyl, butyl,t-butyl, pentyl, hexyl, cyclohexyl, heptyl, octyl, nonyl, decyl, benzyl,and phenylethyl. A phase transfer agent having 2 or more alkyl groupscan contain the same or different alkyl groups. Among the alkylammoniumsalts, the phase transfer agents are commonly tetralkylammonium salts,though mono-, di- and tri-alkyl ammonium salts can also be used.

The amount of phase transfer agent to be used can readily be determinedby routine experimentation, since it is very simple to observe whenligand exchange is occurring by visual monitoring of the migration ofthe nanoparticle from the nonaqueous phase into the aqueous phase. Inaddition to those disclosed above, other examples of suitable phasetransfer agents include, but are not limited to, triethylbenzyl ammoniumchloride, tetrabutylammonium bromide, tetrahexylammonium chloride,tetraoctylammonium chloride, and polyethers such as PEG of variousmolecular weights, diglyme, triglyme, or tetraglyme, and cyclicpolyethers such as 12-crown-4, 15-crown-5, and 18-crown-6.

The exchange process can be conducted at room temperature or above.Depending on the hydrophobic ligand to be replaced and the hydrophilicliganed to be added, in some embodiments, it may be advantageous to heatthe mixture to at least about 50° C., up to the boiling point of thesolvent. Suitable temperatures for the exchange are typically betweenabout 50° C. and about 100° C., and commonly between about 50° C. and80° C., such as about 60° C. or about 70° C. Reaction times for thisexchange will vary depending upon the hydrophobic ligand to be replaced,the hydrophilic ligand to be added, the concentration of the hydrophilicligand, and the nature of the phase transfer agent. Reaction times varyfrom less than an hour to several hours and up to a week, depending onthe hydrophobic ligand to be replaced and the hydrophilic ligand to beadded. In some embodiments, an exchange reaction can be conducted tomigrate substantially all of the nanoparticles from the non-aqueousphase into the aqueous phase within 2-6 hours.

Following the exchange reaction, the surface layer of the nanoparticleor populations thereof can be a layer such as described above, havingmultiple functional groups. Dipeptides, tripeptides, monodentate thiols,or polydentate thiols are suitable, as are mixtures of dipeptides,tripeptides, monodentate thiols, or polydentate thiols with hydrophobicligands like TDPA, OPA, TOP, and/or TOPO.

In certain embodiments, the nanoparticle or populations thereof has asurface layer that can be comprised of a mixture of hydrophilic andhydrophobic ligands, wherein the ratio of hydrophilic to hydrophobicligands is at least about 25:1, at least about 20:1, at least about15:1, at least about 10:1, at least about 5:1, at least about 1:1, atleast about 0.9:1, at least about 0.8:1, at least about 0.7:1, at leastabout 0.6:1, at least about 0.5:1, at least about 0.4:1, at least about0.3:1, at least about 0.2:1, at least about 0.1:1, or at least about0.05:1.

In certain embodiments, the nanoparticle or populations thereof has asurface layer that can comprise a mixture of DHLA (i.e., hydrophilicligand) and TDPA (i.e., hydrophobic) ligands, wherein the ratio of DHLAto TDPA ligands is at least about 2.5:1, at least about 1:1, or at leastabout 0.25:1.

In certain embodiments, the nanoparticle or population thereof has asurface layer that can comprise a mixture of tridentate thiols ofFormula I and Formula II (i.e., hydrophilic ligand) and TDPA (i.e.,hydrophobic) ligands, wherein the ratio of tridentate thiols of FormulaI and Formula II to TDPA is at least about 25:1, at least about 20:1, atleast about 15:1, at least about 9:1, at least about 8:1, at least about7:1, at least about 6:1, at least about 5:1, at least about 4:1, atleast about 3:1, at least about 2:1, at least about 1:1, at least about0.5:1, or at least about 0.25:1.

In certain embodiments, the nanoparticle or populations thereof has asurface layer that can comprise a mixture of dipeptides (i.e.,hydrophilic ligand) and TDPA (i.e., hydrophobic) ligands, wherein theratio of dipeptides to TDPA ligands is at least about 5:1, at leastabout 2.5:1, at least about 1.5:1, or at least about 1:1.

When desired, these nanoparticles or populations thereof can be treatedto crosslink the layer of ligands on the nanoparticle surface.Crosslinking can be done by known methods, or by the methods describedbelow. Typically, the nanoparticles or populations thereof are isolatedby conventional methods before crosslinking. In particular, methods forcross-linking nanoparticles or populations thereof coated withhydrophilic ligands (using the methods disclosed herein), are provided.

These methods provide small nanoparticles that are especially desirablefor certain applications. For example, judicious selection of ananocrystal core material permits the nanocrystal core to be as small aspractical for the desired fluorescence wavelength; and a thin shell canthen be used to protect the core without unduly enlarging thenanocrystal. The use of small hydrophilic ligands like the dipeptidesand thiols actually makes the nanoparticle smaller than a conventionalone having large hydrophobic ligands like TDPA, OPA, TOPO or TOP. Thesurface layer of hydrophilic ligands can then be crosslinked to enhancestability without significantly increasing the overall size of thenanoparticle. Using this process, stable, cross-linked nanoparticles orpopulations thereof that are water soluble and have a diameter less thanabout 20 nm can be prepared. In some embodiments, the overallparticle(s) size is less than about 8 nm, or it is about 7 nm or less,or about 6 nm or less, or about 5 nm or less, or less than 5 nm. Themethods are of course applicable to nanoparticles or populations thereofthat are elongated or rod shaped as well as ones that are generallyspherical; in such embodiments, this dimension refers to the smallestdimension of the particle rather than its average diameter.

These small particles are advantageous for many applications, becausethey can promote faster diffusion than larger particles like the AMPcoated particles of Adams et al., which can permit more rapiddistribution in vivo. They can be particularly useful for labelingmolecules where a single molecule needs to be tracked for a prolongedperiod of time, because the small size of these particles means they mayinterfere less with the movement and structural characteristics of asingle molecule. In addition, their improved stability can reduce‘dilution dimming’, so these nanoparticles are well suited for use in avariety of biological applications.

A typical single-color preparation of nanoparticles has crystals thatcan be of substantially identical size and shape. Nanocrystals aretypically thought of as being spherical or nearly spherical in shape,but can actually be any shape. Alternatively, the nanocrystals can benon-spherical in shape. For example, the nanocrystal's shape can changetowards oblate spheroids for redder colors. In some embodiments, atleast about 60%, at least about 70%, at least about 80%, at least about90%, at least about 95%, and ideally about 100% of the particles are ofthe same size. Size deviation can be measured as root mean square(“rms”) of the diameter, with less than about 30% rms, preferably lessthan about 20% rms, more preferably less than about 10% rms. Sizedeviation can be less than about 10% rms, less than about 9% rms, lessthan about 8% rms, less than about 7% rms, less than about 6% rms, lessthan about 5% rms, or ranges between any two of these values. Such acollection (i.e., population) of particles is sometimes referred to asbeing “monodisperse”. One of ordinary skill in the art will realize thatparticular sizes of nanocrystals, such as of nanocrystals, are actuallyobtained as particle size distributions.

It is well known that the color (emitted light) from the nanocrystal(i.e., quantum dot) or populations thereof can be “tuned” by varying thesize and composition of the nanocrystal. Nanocrystal(s) can absorb awide spectrum of wavelengths, and emit a narrow wavelength of light. Incertain embodiments, the excitation and emission wavelengths aredifferent, and non-overlapping. The nanoparticles of a monodispersepopulation may be characterized in that they produce a fluorescenceemission having a relatively narrow wavelength band. Examples ofemission widths (FWHM) include less than about 200 nm, less than about175 nm, less than about 150 nm, less than about 125 nm, less than about100 nm, less than about 75 nm, less than about 60 nm, less than about 50nm, less than about 40 nm, less than about 30 nm, less than about 20 nm,and less than about 10 nm. The width of emission is preferably less thanabout 100 nm, and more preferably less than about 35 nm at full width athalf maximum of the emission band (FWHM). The emitted light preferablyhas a symmetrical emission of wavelengths. The emission maxima cangenerally be at any wavelength from about 200 nm to about 2,000 nm.Examples of emission maxima include about 200 nm, about 400 nm, about600 nm, about 800 nm, about 1,000 nm, about 1,200 nm, about 1,400 nm,about 1,600 nm, about 1,800 nm, about 2,000 nm, and ranges between anytwo of these values.

Frequently, the fluorescence of a monodisperse population of thenanocrystals disclosed herein is characterized in that when irradiatedthe population emits light for which the peak emission is in thespectral range of from about 370 nm to about 1200 nm, sometimes fromabout 370 nm to about 900 nm, and sometimes from about 470 nm to about800 nm.

The nanoparticle(s) can have surface coatings adding variousfunctionalities. For example, the nanocrystal(s) can be coated withlipids, phospholipids, fatty acids, polynucleic acids, polyethyleneglycol, primary antibodies, secondary antibodies, antibody fragments,protein or nucleic acid based aptamers, biotin, streptavidin, proteins(e.g., enzymes, etc.), peptides, small organic molecules, organic orinorganic dyes, precious or noble metal clusters.

Spectral characteristics of nanoparticles can generally be monitoredusing any suitable light-measuring or light-accumulatinginstrumentation. Examples of such instrumentation are CCD(charge-coupled device) cameras, video devices, CIT imaging, digitalcameras mounted on a fluorescent microscope, photomultipliers,fluorometers and luminometers, microscopes of various configurations,and even the human eye. The emission can be monitored continuously or atone or more discrete time points.

The nanoparticle(s) disclosed herein frequently comprise a core/shellnanocrystal comprising a nanocrystal core covered by a semiconductorshell characterized by its thickness. The thickness of the shell can beadapted to provide desired particle properties. The thickness of theshell can affect fluorescence wavelength, quantum yield, fluorescencestability, and other photostability characteristics.

In some embodiments, a core nanocrystal or populations thereof can bemodified to enhance the efficiency and stability of its fluorescenceemissions, prior to ligand modifications described herein, by adding anovercoating layer or shell to the nanocrystal core. Having a shell maybe preferred, because surface defects at the surface of the nanocrystalcan result in traps for electrons or holes that degrade the electricaland optical properties of the nanocrystal core, or other non-radiativeenergy loss mechanisms that either dissipate the energy of an absorbedphoton or at least affect the wavelength of the fluorescence emissionslightly, resulting in broadening of the emission band. An insulatinglayer at the surface of the nanocrystal core can provide an atomicallyabrupt jump in the chemical potential at the interface that eliminateslow energy states that can serve as traps for the electrons and holes.This results in higher efficiency in the luminescent processes.

Suitable materials for the shell include semiconductor materials havinga higher bandgap energy than the nanocrystal core. In addition to havinga bandgap energy greater than the nanocrystal core, it may be desirablefor the shell to have good conduction and valence band offset withrespect to the core nanocrystal. Thus, the conduction band is desirablyhigher and the valence band is desirably lower than those of the corenanocrystal. For nanocrystal cores that emit energy in the visible(e.g., CdS, CdSe, CdTe, ZnS, ZnSe, ZnTe, GaP, GaAs, GaN) or near IR(e.g., InP, InAs, InSb, PbS, PbSe), a material that has a bandgap energyin the ultraviolet regions may be used. Exemplary materials include CdS,CdSe, InP, InAs, ZnS, ZnSe, ZnTe, GaP, GaN, and magnesium chalcogenides,e.g., MgS, MgSe, and MgTe. For a nanocrystal core that emits in the nearIR, materials having a bandgap energy in the visible, such as CdS orCdSe, may also be used. The preparation of a coated nanocrystal may befound in, e.g., Dabbousi et al. (1997) J. Phys. Chem. B 101:9463, Hineset al. (1996) J. Phys. Chem. 100: 468-471, Peng et al. (1997) J. Am.Chem. Soc. 119:7019-7029, and Kuno et al. (1997) J. Phys. Chem.106:9869. It is also understood in the art that the actual fluorescencewavelength for a particular nanocrystal core depends upon the size ofthe core as well as its composition, so the categorizations above areapproximations, and nanocrystal cores described as emitting in thevisible or the near IR can actually emit at longer or shorterwavelengths depending upon the size of the core.

In another aspect, methods for cross-linking a surface layer on ananoparticle or populations thereof, are provided. The surface layer tobe cross-linked may be hydrophobic or hydrophilic; in some embodiments,it is a hydrophilic surface layer such as those provided above. It mayalso be a mixed surface layer, comprising some hydrophilic ligands andsome hydrophobic ligands, which may exist as hydrophilic domainsinterspersed with hydrophobic domains on the surface; or the ligands maybe intimately mixed. Mixtures of ligands can result where ligandexchange is not complete, such as when the exchange process is stoppedas soon as the nanoparticles become water soluble. The overall characterof a nanoparticle or populations thereof thus is not necessarily a clearindication of its ligands, as a given nanoparticle or nanoparticlepopulation may have some hydrophobic ligands on its surface and yet,overall, have sufficient hydrophilic surface to be water-soluble.

In some embodiments, at least about 10% of the hydrophobic ligands areexchanged for hydrophilic ligands. In other embodiments, at least about20%, at least about 30%, at least about 40%, at least about 50%, atleast about 60%, at least about 70%, at least about 80%, at least about90%, or about 100% of the hydrophobic ligands are exchanged forhydrophilic ligands.

In some embodiments, at least about 10% of the surface of thewater-dispersible nanoparticle or populations thereof is coated withhydrophilic ligands. In other embodiments, at least about 20%, at leastabout 30%, at least about 40%, at least about 50%, at least about 60%,at least about 70%, at least about 80%, at least about 90%, or about100% of the water dispersible nanoparticle or populations thereofsurface is coated with hydrophilic ligands.

The surface layer can be, for example, a layer such as described above,having multiple functional groups. Dipeptides, tripeptides, monodentatethiols, or polydentate thiols are suitable, as are mixtures ofdipeptides, tripeptides, monodentate thiols, or polydentate thiols withhydrophobic ligands like TDPA, OPA, TOP, and/or TOPO.

The nanoparticle or populations thereof can be any nanocrystal orpopulation of nanocrystals having a coating layer of organic molecules.The cross-linking process is believed to increase stability of thenanoparticle, possibly by reducing the ability of ligands to desorb fromthe nanocrystal surface. Frequently, though not exclusively, thenanocrystal surface is coated with a surface layer that promotes watersolubility. In some embodiments, the nanoparticle or populations thereofis made by the method described above, by exchange of hydrophobicsurface ligands for hydrophilic ligands.

Suitable solvents can be any solvent effective to disperse thenanoparticles to be crosslinked. Where the nanoparticle(s) arehydrophobic, an organic solvent that disperses the nanoparticles isappropriate; examples of suitable solvents include hexanes and otheralkane solvents, toluene and other aromatic solvents; THF, ethylacetate, chloroform, dichloromethane, MTBE, and mixtures of these. Wherethe nanoparticle(s) are water-dispersable, the solvent can be an aqueoussolvent. In some embodiments, the aqueous solvent is a buffer. Bufferedaqueous solvents and other aqueous solvents can include co-solvents suchas THF, DME, dioxanes, or alcohols as appropriate to ensure solubilityof the crosslinking agents and nanoparticle(s). Suitable buffers includebut are not limited to PBS, HEPES, bicarbonate, and borate.

A variety of cross-linking agents can be used. In general, the selectedcross-linking agent should be able to link together two or more ligandson the surface of the nanocrystal. In some embodiments, a cross-linkingagent can be a compound that includes one or more amine groups such as adiaminoalkane (e.g., 1,2-diaminoethane, 1,3-diaminopropane,1,4-diaminobutane, or 1,6-diaminohexane), or a polyamine (e.g.polyethyleneimine). In other embodiments, the cross-linking agent can bea compound that includes one or more carboxylate groups (e.g.ethylenediamine tetraacetate or polyacrylic acid). In still otherembodiments, the cross-linking agent can be a compound that includes acombination of amine and carboxylate groups (e.g. lysine and glutamicacid each comprise both amino and carboxyl groups).

It should be understood, however, that the cross-linking agent canessentially be any compound that can link together two or more ligandson the surface of the nanocrystal. Examples of cross-linking agents caninclude, but are not limited to: polycarbodiimide or a hydroxymethylphosphorus compounds such as tris(hydroxymethyl)phosphines (THP) ortris(hydroxymethyl)phosphonium propionate (THPP) or a poly-succinimidylester or a sulfur mustard (e.g. 1,5-dichloro-3-thiapentane); compoundsthat include phosgene or triphosgene; or compounds that are comprised ofatomic sulfur.

In some embodiments, cross-linking will be enhanced via the introductionof cross-linkable groups after ligand exchange. For example, anyphotoreactable molecule modified by any orthogonally cross-linkablefunctional groups could be used to prepare cross-linked nanoparticles.In particular, benzophenone derivatives modified with any cross-linkablefunctional group (e.g., an amine, a carboxylic acid, a thiol, etc.) canbe utilized. In one embodiment, the photoreactable molecule is anaminobenzophenone derivative, which can be used under photolyticconditions. Without being bound to a specific mechanism, it is believedthat upon irradiation the benzophenone derivative is activated as aradical species and becomes grafted to the coating of the nanoparticle,usually by forming a carbon-carbon bond to the coating molecules. Itthen has a free amine group that can be used for cross-linking. Inanother embodiment, the photoreactable group is 4-aminobenzophenone.Other benzophenone derivatives are also useful, including, e.g.,aminomethylbenzophenone, diaminobenzophenone, anddiaminomethylbenzophenone, which can be used similarly toaminobenzophenone.

Where the coating layer on the nanoparticle or populations thereofcomprises amino acids such as dipeptides having at least one thiol orimidazole group for binding to the nanocrystal surface, crosslinking canbe achieved with just a peptide bond-forming agent, which formscrosslinks between the amines and carboxylates of adjacent dipeptidemolecules. Since a dipeptide includes a carboxylate and an amine, it canbe linked to two other surface layer ligands, as is required forcrosslinking of small molecules to be effective.

Combinations of two or more crosslinking agents may also be used whereappropriate. For example, where the coating layer comprises freecarboxylate groups, a diaminoalkane can be used as a crosslinking agent,and it would be used along with a peptide-bond forming agent such as acarbodiimide. Where the coating layer comprises free amine groups, itcan be crosslinked by use of a hydroxymethyl phosphorus compound. Evenif the coating comprises neither carboxylates nor amines, it can befunctionalized by photolysis with a photoreactable molecule containing across-linkable functional group. For example, photolysis with4-aminobenzophenone introduces free amines, which can be crosslinkedwith a hydroxymethyl phosphorus compound as a crosslinking agent.

Some specific examples of the overall process for making nanoparticle(s)by the above methods can include, after the exchange has proceeded tothe stage where substantially all of the nanoparticles have migratedinto the aqueous phase:

-   -   (1) cross-linking the nanoparticles with polycarbodiimide        (PCDI), using 0.7 micromolar solution of the nanoparticles plus        100 micrograms/mL PCDI having a molecular weight ca. 2000. The        product can then be isolated by a dialysis step as discussed        herein.    -   (2) dialyzing the nanoparticles to clean them up, then mixing        with 500 micrograms/mL PCDI, then treating with diaminobutane        and THP to further crosslink prior to dialysis.    -   (3) dialyzing the nanoparticles, crosslinking with one or more        treatments with THP and diaminobutane, then dialyzing again.

Each of these methods provided nanoparticle(s) that were at stable athigh dilution as demonstrated by stability in PBS at room temperature ata concentration of 70 nM for at least 2 days.

In some instances, the products made by the above methods were furthermodified by conjugation, using EDC (a carbodiimide) and s-NHS(sulfo-N-hydroxysuccinimide) to activate a PEG-COOH moiety by forming aPEG-CO—NHS intermediate, then using the activated PEG-CO—NHSintermediate to acylate an amine on the nanoparticle surface. Where thesurface layer does not contain a sufficient amount of free amine forthis PEGylation method, it can be photolyzed, for example with4-aminobenzophenone or a suitable photoreactive amine, to installamine-containing functional groups, and then the installed amine(s) canbe acylated with the activated PEG-CO—NHS intermediate.

In addition to attaching PEG, the carboxylates of the peptide-coatednanoparticle(s) can be used to connect the nanoparticle to a cargomolecule that can then be monitored by watching the fluorescence of thenanocrystal in the nanoparticle. Such uses of nanoparticle(s) fortracking molecules or cells are known in the art, and the presentnanoparticles are particularly useful for such methods. Methods forattaching such ‘cargo’ to the nanoparticles disclosed herein are known,and often involve forming an amide bond to the carboxylate group to linkthe cargo molecule to the nanoparticle. The cargo molecule can be a DNAor RNA, or other nucleic acid or nucleic acid analog; or it can be anaffinity molecule such as an antibody; or it can be a protein or enzymeor a receptor; or it may be an oligosaccharide, or other biomolecule.Some suitable cargo molecules are disclosed as ‘affinity molecules’ inU.S. Pat. No. 6,423,551, to Weiss, et al., and include monoclonal andpolyclonal antibodies, small molecules such as sugars, drugs, andligands. Methods for attaching such cargo (affinity) molecules to acarboxylate group on the nanoparticles disclosed herein are well known.

Dilution Dimming

It has been observed that nanoparticles have an unfortunate tendency tolose brightness when they are diluted to very low concentrations. SeeFIG. 2, which illustrates that conventional nanoparticles tend to bequite stable in solution/dispersion over a wide concentration range, butcan precipitate at higher concentrations, or lose fluorescence andprecipitate at lower concentrations. This can make it more difficult touse such nanoparticles for applications that involve, e.g., use in abiochemical/biological environment. While the mechanism for the loss offluorescence at low concentration, which is referred to herein asdilution dimming, is not known, it may be due to a tendency to loseligands from the nanoparticle surface. The surface ligands appear toenhance stability of nanocrystals, presumably by protecting the surfacefrom degradative interactions with the environment, and their loss, eventemporarily, may permit degradation

Because solution stability and stability at high dilution is important,the nanoparticles described herein can be characterized by theirstability at high dilution in an aqueous medium to demonstrate theiradvantages. For this purpose, nanoparticles are diluted to a lowconcentration, such as 10-100 nm, and observed over time to see how longthe suspension is stable. This can be judged by watching visually forformation of a precipitate indicating that the nanoparticles have lostintegrity. Various buffers can be used to test the nanoparticles in thisway. After testing several different buffers, it was found that 1×PBS atph 7.4 could be used to test the stability of aqueous-solublenanoparticles. Nanoparticle or populations thereof made water soluble byprevious methods precipitated in about 1 week on standing at roomtemperature in 1×PBS under these conditions. Other buffers testedinclude 50 mM borate at pH 9, and 20 mM HEPES at pH 8 (in whichnanoparticles in the prior art were reportedly stable for severalweeks). The nanoparticles described herein were prepared and crosslinkedwith THP, and were tested in the 1×PBS buffer at 60 nM to comparestability at high dilution.

While conventional nanocrystals appear to be quite stable in solution atroughly micromolar concentrations (see FIG. 2), they may nonethelesshave a tendency to dissociate. At those concentrations, the affinity forligands may be high enough to keep the surface essentially fullyoccupied all the time because ‘loose’ (desorbed) ligands are present ata high enough concentration to ensure rapid recombination: vacantligand-binding sites would not stay vacant for long with some ligandpresent. However, the rate of recombination of a nanoparticle that losta ligand would be dependent on the concentrations of both thenanoparticle and the free ligand. At very low concentrations, the veryslow loss of ligand may leave a particle that has an open binding spoton its surface exposed long enough for degradation of the surface tooccur, because recombination becomes very slow. Regardless of themechanism, however, dilution dimming is detrimental for applicationswhere a nanoparticle may need to be observed for a period of time in anenvironment where nanoparticle concentration is extremely low.

In one aspect, nanoparticle(s) that are cross-linked and are less proneto dilution dimming than previously known nanoparticles, are provided.FIG. 3 compares a nanoparticle that has a cross-linked coating surfacewith a nanoparticle having a coating of an amphiphilic polymer asdisclosed by Adams, et al., and shows that the nanoparticles with across-linked surface are far less affected by dilution dimming. Whilethe AMP nanoparticle lost about 40% of its initial emission intensitywithin about two hours, the dipeptide-coated nanoparticle made by thepresent exchange method retained about 90% of its initial intensity bythat time, and maintained over 80% of its initial emission intensitybeyond 250 minutes.

Ligand Exchange Process for Making Water-Soluble Nanoparticles

The ligand exchange processes described herein permit efficientconversion of a conventional hydrophobic nanoparticle or populationsthereof into a water-dispersable nanoparticle or population ofnanoparticles. It also permits preparation of small nanoparticles thatare highly stable and bright enough to be useful in biochemical andbiological assays.

The ligand exchange process can be used to apply various types ofligands to the surface of a nanoparticle, by substituting a desiredhydrophilic ligand for a conventional hydrophobic ligand like TOPO, TOP,TDPA, OPA, and the like. Dipeptides comprising at least one imidazole orat least one thiol group for binding to the nanocrystal may beparticularly suitable for use in these methods. Such dipeptides areknown to provide stabilized nanoparticles, and they provide free amineand/or carboxylate groups to facilitate cross-linking, which can furtherstabilize the coating layer. However, it should be understood that othersuitable hydrophilic ligands may also be used.

The methods described herein for exchanging ligands on a nanoparticle orpopulations thereof utilize phase transfer catalysts that areparticularly effective, and provide faster exchange reactions. Butanolhas been utilized as a phase transfer catalyst for this type of exchangereaction; however, the reaction takes several days typically, andrequires heating to about 70° C. The time for this reaction exposes thenanoparticles to these reaction conditions for a long period of time,which may contribute to some reduction in its ultimate stability. Theembodiments disclosed herein provide more efficient conditions thatachieve ligand exchange more rapidly, thus better protecting thenanoparticles. As a result of accelerating the exchange reaction andallowing use of milder conditions, these phase transfer catalystsproduce higher quality nanoparticles.

The phase transfer agent for this process can be a crown ether, a PEG, atrialkylsulfonium, a tetralkylphosphonium, and an alkylammonium salt, ora mixture of these. In some embodiments, the phase transfer agent is18-crown-6, 15-crown-5, or 12-crown-4. In some embodiments, the phasetransfer agent is a PEG, which can have a molecular weight from about500 to about 5000. In some embodiments, the phase transfer agent is atrialkylsulfonium, tetralkylphosphonium, or alkylammonium (includingmonoalkylammonium, dialkylammonium, trialkylammonium andtetralkylammonium) salt.

Tetralkylammonium salts are sometimes preferred as phase transferagents. Examples of suitable tetralkylammonium salts includetriethylbenzyl ammonium, tetrabutylammonium, tetraoctylammonium, andother such quaternary salts. Other tetralkylammonium salts, where eachalkyl group is a C1-C12 alkyl or arylalkyl group, can also be used.Typically, counting all of the carbons on the alkyl groups of atrialkylsulfonium, tetralkylphosphonium, and alkylammonium salt, thephase transfer agent will contain a total of at least 2 carbons, atleast 10 carbons and preferably at least 12 carbon atoms. Each of thetrialkylsulfonium, tetralkylphosphonium, and alkylammonium salts has acounterion associated with it; suitable counterions include halides,preferably chloride or fluoride; sulfate, nitrate, perchlorate, andsulfonates such as mesylate, tosylate, or triflate; mixtures of suchcounterions can also be used. The counterion can also be a buffer orbase, such as borate, hydroxide or carbonate; thus, for example,tetrabutylammonium hydroxide can be used to provide the phase transfercatalyst and a base. Specific phase transfer salts for use in thesemethods include tetrabutylammonium chloride (or bromide) andtetraoctylammonium bromide (or chloride). FIG. 4A, FIG. 4B, FIG. 4C andFIG. 4D illustrate how easily one can observe the exchange process bywatching the nanoparticles migrate from the non-aqueous layer into theaqueous layer, and demonstrates that the reactions with preferred phasetransfer catalysts are particularly efficient and effective.

Suitable hydrophilic ligands are organic molecules that provide at leastone binding group to associate tightly with the surface of ananocrystal. The hydrophilic ligand typically is an organic moietyhaving a molecular weight between about 100 and 1500, and containsenough polar functional groups to be water soluble. Some examples ofsuitable hydrophilic ligands include small peptide having 2-10 aminoacid residues (preferably including at least one histidine or cysteineresidue), mono- or polydentate thiol containing compounds.

Following ligand exchange, the surface layer can optionally becrosslinked.

The stability of nanoparticles can be assessed by observing how long thenanoparticles remain dispersed in an aqueous medium. The nanoparticlesdisclosed herein were assessed for stability when dispersed at lowconcentration in various types of buffers; instability was observed bynoting how long the nanoparticles remain dispersed before precipitation.Precipitation indicates that the nanoparticle or populations thereof isdegrading.

Crosslinking Methods

In addition to the above-described methods for introducing awater-solubilizing coating layer onto a nanocrystal (i.e., preparingwater-soluble nanoparticles), the embodiments disclosed herein alsoprovides robust methods for crosslinking a coating or layer of moleculeson the surface of a nanoparticle. The nanoparticle can be any suitablenanocrystal having a layer of molecules that are tightly associated withits surface. The tightly associated molecules will typically be onesthat coordinate effectively to the metal atoms in the shell of acore/shell nanocrystal. Such molecules typically contain one or morefunctional groups that cause them to associate with the nanocrystalsurface, such as, for example, a phosphine or phosphine oxide; aphosphonic or carboxylic acid; a thiol; an imidazole; an amine; andsimilar groups that bind well to a nanocrystal surface. The molecule maycontain two or more of such functional groups, and may containadditional functional groups that are not necessarily needed for closeassociation with the surface.

The molecules on the nanocrystal surface to be crosslinked can behydrophobic or hydrophilic, and frequently the molecules will be amixture of hydrophilic and hydrophobic ones. The molecules on thesurface of the nanocrystal determine the overall solubility propertiesof the nanoparticle, so the surface overall can be characterized by itssolubility properties as either hydrophobic (dispersable in nonpolarsolvents like hexanes, and not water dispersable), hydrophilic (waterdispersable), or amphiphilic (dispersable in polar organic solvents butnot readily dispersable into water). Frequently, the surface layer ofmolecules will comprise hydrophilic molecules such as those describedherein, to impart water solubility to the nanoparticle. In someembodiments, the nanoparticle or populations thereof is made by theabove-described methods for exchanging hydrophobic surface ligands withhydrophilic ligands to provide a water-soluble nanoparticle orpopulation of nanoparticles.

These methods involve making a crosslinked surface on a nanoparticle,where the method comprises:

-   -   a) providing a nanocrystal dispersed in an aqueous phase,        wherein the nanocrystal is coated with a surface layer of        molecules or ligands;    -   b) adding to the nanocrystal dispersion a crosslinking agent, or        a peptide bond-forming agent, or both a crosslinking agent and a        peptide bond-forming agent; and    -   d) incubating the dispersion under conditions suitable to        crosslink the molecules of the surface layer.

The nanoparticle for this process is usually a core/shell nanocrystalhaving a layer of molecules on its surface, and the method is used tofurther stabilize the nanoparticle by increasing the stability of thesurface layer of molecules, or by decreasing the tendency of the surfacelayer of molecules to desorb from the nanocrystal. In some embodiments,the nanocrystal is a water-dispersable nanocrystal or populationsthereof made by the ligand exchange processes described herein, whereinthe surface comprises hydrophilic ligands.

A variety of methods for crosslinking the surface layer on ananoparticle can be used, depending upon the composition of the surfacelayer. If the surface layer comprises available functional groups thatare readily used, it can be functionalized using known reagents andmethods suitable for use with those functional groups. For example, ifthe surface layer comprises free amine groups, crosslinking can beachieved by, for example, reacting the surface layer with ahydroxymethyl phosphorus compound such as THP or THPP. If thenanoparticle is water soluble already, THP is sometimes preferred forthis step.

If the surface layer comprises amines and carboxylates (which occurswhen the surface layer comprises dipeptides having a thiol or imidazole,group, for example), it can be crosslinked by adding just a peptide-bondforming agent. However, when the surface layer do not contain suitablefunctional groups for amide bond formation, the crosslinking process caninclude a step of introducing such functional groups, followed by a stepof forming peptide bonds using a peptide bond-forming agent. Examples ofsuch dehydrating agents include carbodiimides (e.g., DCC, DIPC, EDC,polycarbodiimide), CDI, and the like, and optionally an activatingreagent used with such dehydrating agents (e.g., N-hydroxysuccinimide;1-hydroxybenzotriazole; etc.).

Thus in some embodiments, the methods include adding at least onecrosslinking agent selected from a hydroxymethyl phosphorus compound,aminobenzophenone, diaminobenzophenone, aminomethylbenzophenone,diaminomethylbenzophenone, and a diaminoalkane. Either separately orconcurrently, where necessary, the nanoparticle will also be contactedwith a peptide bond-forming agent, such as a carbodiimide.

One suitable crosslinking agent is a functionalized benzophenone, suchas 4-aminobenzophenone. Other functionalized benzophenones, such as adiaminobenzophenone, an aminomethylbenzophenone, or adiaminomethylbenzophenone can also be used. These reagents can be usedwith any nanoparticle having a layer of surface molecules, because theycan photochemically react with either a hydrophobic or hydrophilicsurface molecule, even if the surface molecule does not comprise afunctional group specifically for such reactions: a benzophenone willinsert into C—H bonds when photolyzed, so it can be attached tovirtually any organic molecules on a surface of a nanoparticle tointroduce an amine group. As long as the benzophenone has a functionalgroup that can be used to form a covalent bond to another surface layermolecule, too, in addition to the bond formed by its photochemicalgrafting onto an available alkyl group, it can be a crosslinking agent.One example of such a benzophenone is 4-aminobenzophenone. Its aminegroup can be used to covalently attach to an amine, carboxylate or otherfunctional group on a molecule of the surface layer; or two amines fromtwo molecules of 4-aminobenzophenones can be linked together by knownmethods to connect to two different molecules on the surface layer.Photolysis either before or after attachment of the amines to surfacelayer molecules provides an effective crosslinking of the surface layermolecules.

In some embodiments, a diaminoalkane is used as a crosslinking agent. Adiaminoalkane provides two amine groups linked together, and if each ofthose amine groups is then linked to a molecule on the surface of ananoparticle, it crosslinks those surface layer molecules. The amines ofa diamine can be linked to carboxylate groups on surface layer moleculesusing peptide bond-forming reactions and reagents, such ascarbodiimides. Carboxylates for this type of crosslinking are availableon the amphiphilic polymer compounds (AMPs) disclosed in Adams, et al.,which can be placed on the surface of a nanoparticle; thusdiaminoalkanes can be used as a crosslinking agent for surface layermolecules like these AMPs. Similarly, carboxylate groups of polypeptidescan be crosslinked using diaminoalkanes.

Suitable diaminoalkanes include any saturated hydrocarbon group havingtwo amines attached. Examples to be mentioned include 1,2-diaminoethane;1,3-diaminopropane; 1,4-diaminobutane; 1,3-diamino-2,2-dimethylpropane;1,6-diaminohexane, 1,4-diaminocyclohexane, and the like.

The embodiments disclosed herein also provide nanoparticles made by theabove methods. Such nanoparticles can utilize any quantum dot or similarfluorescent core/shell nanocrystal, and can be further modified forattaching a target molecule or a cargo molecule to be monitored ordelivered.

The following examples are offered to illustrate but not to limit theembodiments disclosed herein.

Example 1 Exchange Process Using Dipeptide Ligands and Butanol as aCosolvent

Core/shell nanocrystals (quantum dots) were prepared by standardmethods, and were washed with acetic acid/toluene several times, andsuspended in hexanes. 10 nmol of core/shell nanocrystals were suspendedin 40 mL hexane. This was mixed with 10 mL of a 300 mM solution ofcarnosine and 10 mL of 1 M sodium carbonate solution. n-Butanol (14 mL)was added, and the vessel was flushed with argon. The mixture was mixedvigorously overnight at room temperature. The mixture was then heatedand allowed to cool to room temperature. The aqueous phase was thenremoved and filtered through a 0.2/0.8 micron syringe filter.

Excess carnosine was removed by dialyzing against 3.5 L of 25 mM NaClfor one hour. The solution was concentrated to 1 mL using a 10K MWCO(10,000 molecular weight cut-off) Amicon centricon. A solution was thenprepared with 568 mg of His-Leu dipeptide plus 212 mg of Gly-Hisdipeptide in 9 mL sodium carbonate solution, and this solution wascombined with the aqueous solution of quantum dots. This mixture wasstirred overnight at room temperature. The mixture of water-solublequantum dots was then dialyzed against 3.5 L of 25 mM NaCl for one hour.

To crosslink the peptide ligands (clarify) A solution of 0.5 mM4-aminobenzophenone in ethanol was then added to the aqueous quantumdots mixture, and the mixture was irradiated at 365 nm for 4 hours toeffect reaction of the aminobenzophenone with the surface molecules onthe quantum dots. To this, 5 mmol of THP (tris(hydroxymethyl)phosphine)was added, and the mixture was stirred at RT overnight, to inducecrosslinking. Another 5 mmol of THP was added, and again the mixture wasstirred overnight at RT. Another 5 mmol of THP was added the next day,along with 300 micromoles of PEG₁₀₀₀-COOH. This was mixed overnight atroom temperature, then another 5 mmol of THP was added along with 30mmol of glycine, and the mixture was stirred overnight at RT.

The material was purified by dialysis using the 10K MWCO Amiconcentricon, and was washed with 50 mM borate buffer (pH 9). The finalmaterial was dispersed into 50 mM borate buffer to a final concentrationof 2.5 micromolar for storage.

Example 2 Exchange Process Using Trithiol Ligands

A solution of hydrophobic phosphonate-coated quantum dots in organicsolvent (e.g. toluene, chloroform, etc) with a concentration of betweenabout 0.1 and 10 micromolar quantum dots was prepared. Approximately1000 to 1000000 equivalents of a suitable trithiol ligand was added,optionally as a solution in a suitable organic solvent (e.g. acetone,methanol, etc). The reaction mixture was stirred for 1-48 hours and thenthe solution was basicified by addition of an organic base (e.g.tetramethylammonium hydroxide, tetrabutylammonium hydroxide, etc). Aftera shorter second stirring period, water or aqueous buffer was used toextract the dots with hydrophilic ligands. The aqueous solution waswashed with additional organic solvent (e.g. toluene, chloroform, etc)and purified by filtration.

Example 3 XPS Plots of Relative Surface Content of Exchanged DHLALigands to TDPA Ligand

Core/Shell Nanoparticle Surface Coating Ligand Ratio Tripod(Tripod/TDPA) 6 to 25

The XPS plots (FIG. 5, FIG. 6 and FIG. 7) and table shown in FIG. 9summarizes X-ray Photoelectron Spectroscopy (XPS) data on the relativesurface content of the exchanged hydrophilic surface ligands (e.g.,DHLA, tripod) to TDPA ligands coating DHLA coated and tridentate thiol(i.e., tripod) coated core/shell nanoparticles.

The DHLA and tripod coated dots were analyzed using the followingprotocol:

1. Samples (i.e., the coated dots) in buffer were first exchanged withdH₂O five times using a 10K WMCO centricon whereupon the water dispersedsample was subjected to lyophilization to dryness. Solvent dispersedsamples were not treated in any special manner except to ensure thatthey have been sufficiently cleaned according to established protocols

2. Buffer exchanged samples were dispersed in CHCl₃ and drop cast on asilicon wafer support. Solvent dispersed samples were drop cast directlyon a silicon wafer support.

3. Samples were then analyzed using a Thermo Scientific ESCALAB 250equipped with the Thermo Avantage suite of analysis and operationssoftware.

While certain embodiments have been described above, it will beunderstood that the embodiments are described by way of example only.Those skilled in the art will appreciate that the same can be performedwithin a wide range of equivalent parameters, concentrations, andconditions without departing from the spirit and scope of theembodiments disclosed herein and without undue experimentation.Accordingly, the compositions/compounds, processes and/or methodsdescribed herein should only be limited in light of the claims thatfollow when taken in conjunction with the above description andaccompanying drawings.

What is claimed:
 1. A method for making a water-dispersable nanoparticlecomprising: a. providing a nanocrystal coated with a surface layercomprising a hydrophobic ligand, and dissolved or dispersed in anon-aqueous solvent; b. contacting the nanocrystal dispersion with aphase transfer agent and an aqueous solution comprising a hydrophilicligand, to form a biphasic mixture having an aqueous phase and anon-aqueous phase; and c. maintaining the mixture under conditions thatcause the nanocrystal to migrate from the non-aqueous solvent into theaqueous phase.
 2. The method of claim 1, wherein the phase transferagent is selected from the group consisting of a crown ether, a PEG, atrialkylsulfonium, a tetralkylphosphonium, and an alkylammonium salt. 3.The method of claim 1, wherein the phase transfer agent is 18-crown-6ether.
 4. The method of claim 1, wherein the phase transfer agent istetraoctylammonium bromide.
 5. The method of claim 1, wherein the phasetransfer agent is tetrabutylammonium chloride.
 6. The method of claim 1,wherein the hydrophilic ligand is an organic moiety having a molecularweight between about 100 and 1500, and which is polar enough to be watersoluble.
 7. The method of claim 6, wherein the hydrophilic ligand is asmall peptide having 2-10 amino acid residues.
 8. The method of claim 1,further comprising a step of treating the water-dispersable nanoparticlewith at least one cross-linking agent.
 9. The method of claim 8, whereinthe water-dispersable nanoparticle is isolated prior to treatment withthe at least one cross-linking agent.
 10. The method of claim 8, whereinthe at least one cross-linking agent is selected from a hydroxymethylphosphorus compound, aminobenzophenone, diaminobenzophenone,aminomethylbenzophenone, diaminomethylbenzophenone, or a diaminoalkane.11. A method for making a water-dispersable nanoparticle comprising: a.providing a nanocrystal coated with a surface layer comprising ahydrophobic ligand, and dissolved or dispersed in a non-aqueous solvent;b. contacting the nanocrystal dispersion with at least one cosolvent andan aqueous solution comprising a hydrophilic ligand, to form a biphasicmixture having an aqueous phase and a non-aqueous phase; and c.maintaining the mixture under conditions that cause the nanocrystal tomigrate from the non-aqueous solvent into the aqueous phase; d. whereinthe at least one cosolvent has some miscibility in both the aqueousphase and the non-aqueous phase.
 12. The method of claim 11, wherein theat least one cosolvent is selected from butanol, propanol, isopropanol,ethanol, ethylene glycol, methoxyethanol, dioxane, DME, THF, and DMSO,or mixtures thereof.
 13. The method of claim 11, wherein one cosolventis used.
 14. The method of claim 11, wherein two cosolvents are used.15. The method of claim 11, wherein the hydrophilic ligand is an organicmoiety having a molecular weight between about 100 and 1500, and whichis polar enough to be water soluble.
 16. The method of claim 11, whereinthe hydrophilic ligand is a small peptide having 2-10 amino acidresidues.
 17. The method of claim 11, further comprising a step oftreating the water-dispersable nanoparticle with at least onecross-linking agent.
 18. The method of claim 17, wherein thewater-dispersable nanoparticle is isolated prior to treatment with theat least one cross-linking agent.
 19. The method of claim 17, whereinthe at least one cross-linking agent is selected from a hydroxymethylphosphorus compound, aminobenzophenone, diaminobenzophenone,aminomethylbenzophenone, diaminomethylbenzophenone, or a diaminoalkane.20. A method for making a crosslinked nanoparticle comprising: a.providing a nanocrystal dispersion in buffer, wherein the nanocrystal iscoated with a surface layer comprising a hydrophilic ligand; b. addingto the nanocrystal dispersion a crosslinking agent selected from ahydroxymethyl phosphorus compound, aminobenzophenone,diaminobenzophenone, aminomethylbenzophenone, diaminomethylbenzophenone,and a diaminoalkane; c. adding to the nanocrystal dispersion a peptidebond-forming reagent; d. incubating the dispersion, thereby crosslinkingthe surface layer.